Drug General Information (ID: DDIPW4OYE7)
  Drug Name Oxytetracycline Drug Info Insulin aspart (aspart) Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antibiotics Antidiabetic Agents
  Structure

 Mechanism of Oxytetracycline-Insulin aspart (aspart) Interaction (Severity Level: Moderate)
     Increased risk of hypoglycemia Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Oxytetracycline Insulin aspart (aspart)
      Mechanism Hypoglycemic effects Hypoglycemic effects
      Key Mechanism Factor 1
Factor Name Hypoglycemia
Factor Description Hypoglycemia is a condition in which your blood sugar (glucose) level is below the standard range. It causes irregular or rapid heartbeat, pale skin, numbness of the lips, tongue or cheeks, and sweating.
      Mechanism Description
  • Increased risk of hypoglycemia by the combination of Oxytetracycline and Insulin aspart (aspart) 

Recommended Action
      Management Blood glucose should be monitored closely whenever tetracyclines are prescribed to patients on insulin, especially if they are elderly or have renal impairment. The insulin dosage may require adjustment if an interaction is suspected. Patients should be apprised of the signs and symptoms of hypoglycemia (e.g., headache, dizziness, drowsiness, nausea, hunger, tremor, weakness, sweating, palpitations), how to treat it, and to contact their physician if it occurs.

References
1 Miller JB "Hypoglycaemic effect of oxytetracycline." BMJ 2 (1966): 1007
2 Begin-Heick N, Heick HM, Norman MG "Regranulation of Islets of Langerhans and normalization of in vivo insulin secretion in ob/ob mice treated with oxytetracycline." Diabetes 28 (1979): 65-70
3 Dalpe-Scott M, Heick HM, Begin-Heick N "Insulin secretion in the obese (ob/ob) mouse: the effect of oxytetracycline on insulin release." Diabetes 32 (1983): 932-7